Figure 2
From: Are HIV positive patients resistant to statin therapy?

Rosuvastatin monotherapy vs. Combination therapy. The percentage changes from baseline in lipid parameters of HIV+ patients taking either Rosuvastatin (R) and Fenofibrate (F) combination therapy or Rosuvastatin monotherapy. * indicates p < 0.05.